The biotech’s rough 18 months is nothing compared to what happened 20 years ago, with the chairman saying that he’ll finish in March with his head held high.
Brian McNamee is done with apologising.
The CSL veteran, not known for mincing his words, did everything except physically bow to placate a room full of grumpy shareholders in Melbourne earlier this week as he was asked repeatedly to explain the former blue chip’s fall from grace.
Gift articles to anyone you choose each month when you subscribe.
Compare how 1 other independent news outlet reported on this story.
The Oscar-nominated 1976 adaptation of Stephen King’s high school horror remains heartbreaking and horrifying in equal measure
